The expansion of Tregs via IL-2/IL-2 antibody complexes and brain-targeted IL-2 overexpression in astrocytes via AAV vectors have shown beneficial effects in MCAO and cortical impact mouse models of stroke [342, 343]. The gene discussed is IL2; the disease is Stroke.